Stock Events

Stock Events

Achilles Therapeutics (ACHL) Q1 2024 Earnings

8MayExpected

Q1 2023

Q2 2023

Q3 2023

Q1 2024

-0.46

-0.44

-0.42

-0.4

Details

Expected EPS

-0.46

Actual EPS

-0.46

Surprise EPS

0

Surprise Percent

+0%

Description

Achilles Therapeutics (ACHL) has reported earnings of -0.46 per share for Q1 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.